ANDX is dedicated to helping veterinarians with the early detection and treatment of diseases in companion animals. Our first companion animal product, the FELINE SARCOMA PREDISPOSITION TEST, is a powerful DNA-based diagnostic test that enables the detection of a genetic predisposition to Vaccine Associated Feline Sarcoma (VAFS).
	ANDX FELINE SARCOMA PREDISPOSITION TEST
	VAFS is a type of highly invasive cancer that can develop at sites of vaccination or chronic inflammation in domestic cats. This type of cancer is extremely malignant, and is a cause of concern to small animal practitioners and petowners. ANDX scientists have developed the first FELINE SARCOMA PREDISPOSITION TEST. Veterinarians can use the test results to individualize health management programs for their feline patients and minimize the risk of VAFS development. Test results can also help in choosing appropriate treatments for cats with the disease. The ANDX FELINE SARCOMA PREDISPOSITION TEST is a rapid, non-invasive, once-in-a-lifetime assay that will be available through licensed veterinary practitioners.
	>FAQs on the test	>Particpate in our beta test	>Printable format